Abstract. This meta-analysis was performed to evaluate the association between xeroderma pigmentosum complementary group D (XPD) Lys Gln polymorphism could be a potential biomarker of HCC susceptibility and that the XPD Lys 751 Gln and Asp 312 Asn polymorphisms could be risk factors for HCC susceptibility in an Asian population; however, further large-scale and well-designed studies are required to reach a more precise and comprehensive conclusion.
Introduction
Hepatocellular carcinoma (HCC), as the most common primary cancer of the liver, contributes significantly to rates of cancer-related morbidity and mortality worldwide. The annual estimated incidence of new HCC cases is >0.5 million (1), and the highest incidence rates of HCC (>20/100,000) have been reported in East and Southeast Asian countries. In total, >80% of HCC cases occur in developing countries (2) . Thus, the diagnosis, treatment and prevention of HCC represent significant challenges worldwide. It is well established that the development of HCC is a complex biological process, and the precise mechanism underlying the occurrence of HCC is still not completely understood. Multiple risk factors contribute to HCC susceptibility, such as chronic hepatitis B virus (HBV) infection, aflatoxin B1 (AFB1) intake, smoking and an excessive consumption of alcohol (3) . In addition to these exogenous factors, genetic polymorphisms play an important role in HCC susceptibility.
Within recent decades, several studies have evaluated and highlighted the association between DNA repair genes and hepatocellular neoplasm susceptibility. Nucleotide excision repair (NER) has been proposed to be the most versatile DNA repair mechanism. Xeroderma pigmentosum complementary group D (XPD), also known as excision repair cross-complementing group 2 (ERCC2), is a gene located at Gln AND Asp 312 Asn POLYMORPHISMS AND HCC SUSCEPTIBILITY chromosome 19q13.3 and encodes a type of NER enzyme (4) . Several important single nucleotide polymorphisms have been identified in the XPD locus, with high variant frequencies in exon 10 (rs1799793, codon 312 G→A, Asp→Asn) and exon 23 (rs1052559, codon 751 A→C, Lys→Gln) (5). These two polymorphisms have been largely investigated in genetic epidemiological studies, and individuals with these polymorphisms exhibit a higher risk of developing different types of cancer (6) (7) (8) .
To date, molecular epidemiological studies have investigated the effect of these two polymorphisms on the risk of HCC (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) ; however, the results obtained in these studies have been inconsistent, particularly in an Asian population. In addition, the majority of studies have solely examined the effect of XPD polymorphisms, while only a few studies have explored the interaction of XPD with HBV and other environmental factors. Furthermore, the small sample sizes and missing genotypic data have potentially contributed to false-positive or -negative findings. A meta-analysis is a useful method to overcome the disadvantages of individual studies, thereby increasing the statistical power and precision of the effect estimates (19) . The aim of the present study, therefore, was to perform a meta-analysis of all eligible studies to evaluate the association between Lys
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Gln and Asp 312 Asn polymorphisms and hepatocellular neoplasm susceptibility, and to further explore the interaction between XPD polymorphisms and HBV.
Materials and methods
Search strategy. All case-control studies of XPD polymorphisms and HCC risk published in either the English or Chinese language up to June 1, 2014 were identified by performing systematic searches in PubMed, Embase, Google Scholar, the Chinese National Knowledge Infrastructure (CNKI) and the Chinese Biomedicine databases. The search terms used included: ('XPD' OR 'ERCC2' OR 'DNA repair gene' OR 'xeroderma pigmentosum group D') AND ('polymorphism' OR 'variation' OR 'variant' OR 'genotype' OR 'genetic') AND ('hepatocellular carcinoma' OR 'HCC' OR 'liver cancer' OR 'liver tumour' OR 'liver neoplasms' OR 'hepatic tumour'). The references of each identified article were also manually searched to identify additional relevant publications. If more than one article was published using the same case series, then only the study with the largest sample size was included.
Inclusion criteria. A study was accepted for inclusion in the meta-analysis if it met the following criteria: i) It assessed the correlation between HCC and the XPD Lys Gln or Asp 312 Asn polymorphism in an Asian population; ii) it employed a case-control design; iii) it provided sufficient data regarding the genotypes (Gln/Gln, Lys/Lys, Gln /Lys, Asn/Asn, Asp/Asp and Asn/Asp) to estimate an odds ratio (OR) with a 95% confidence interval (95% CI); and iv) it clearly described the method used to perform the HCC diagnoses and the sources of the cases and controls. When multiple studies containing duplicate or overlapping data were published by the same authors, the most recent study with the largest participant population was selected.
Data extraction. Literature searches and the identification of eligible articles based on the inclusion criteria were conducted in duplicate by two investigators using a standard protocol and data-collection form (20) . The original extracted data were confirmed by another two investigators, and any disagreement was resolved by discussion among the four investigators. The following data were independently extracted: Surname of the first author, ethnicity or country, source of controls, genotyping methods, frequency and genotypes of cases and controls, and the Hardy-Weinberg equilibrium (HWE) of the controls. (21) . If P>0.1 or <50% the study was considered to lack heterogeneity, in which case the pooled OR was calculated for each study using the fixed-effects model. Otherwise, the random-effects model was used (22) . To assess the stability of the results, a sensitivity analysis, in which each study in the meta-analysis was systematically deleted to establish the impact of each individual dataset on the overall pooled OR, was conducted. Furthermore, the potential publication bias was evaluated through visual inspection of the symmetry of the Begg's funnel plots. The statistical analysis of the publication bias was conducted using Egger's test. The meta-analysis was performed using Stata software (version 12.0; StataCorp LP, College Station, TX, USA), and all the P-values were two-sided.
Results
Characteristics of the studies. A flow chart of the exclusion/inclusion of the studies in the meta-analysis is presented in Fig. 1 . A total of 39 potentially relevant publications up to June 1, 2014 were systematically identified using the PubMed, Embase, Google Scholar and CNKI databases. Of these publications, 23 studies (59.0%) were excluded due to a failure to satisfy the inclusion criteria or to provide sufficient information to determine whether the criteria were satisfied. An additional four publications were excluded for one or more of the following reasons: i) They did not examine the XPD Lys
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Gln or Asp 312 Asn polymorphisms; ii) they did not provide allele frequencies, which were required for OR calculation; iii) they deviated from the HWE; iv) they included a family-based control or lacked a control group. Review articles and bibliographies were manually searched to identify relevant studies. A total of 11 studies (9-18; Yu, unpublished data) were ultimately included in this meta-analysis based on the search strategy and inclusion criteria. Four of the 11 studies examined both the XPD Lys Gln polymorphism (9-18; Yu, unpublished data) and four studies (1,753 HCC cases and 1,914 controls) for the XPD Asp 312 Asn polymorphism (11, 13, 15, 17) were retrieved in the final meta-analysis. The characteristics of the included studies are listed in Tables I and II Gene-HBV interaction. In this meta-analysis, four of the studies (9, 11, 12, 15) analysed the gene-HBV interaction. Subgroup analyses were performed based on whether or not the patients had chronic HBV infection, The main results of this Gln polymorphism under the heterozygote comparison (Lys/Gln versus Lys/Lys). The squares and horizontal lines correspond to the study-specific OR and 95% CI. The area of the squares reflects the study-specific weight. The diamond represents the pooled OR and 95% CI. OR, odds ratio; CI, confidence interval. Gln polymorphism/HBV status and HCC risk are presented in the form of forest plots. No significant associations were found in the HBV + and HBV -subgroups.
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Discussion
Worldwide statistics indicate that liver cancer is notably more common among men compared with women. In men, it is the second leading cause of cancer death worldwide and in less developed countries. An estimated 782,500 new liver cancer cases and 745,500 deaths occurred worldwide during 2012, with China alone accounting for ~50% of cases (23) . HCC is the most frequently occurring primary cancer of the liver and the fifth most common solid tumour worldwide.
Between 500,000 and 1,000,000 new cases of HCC are believed to occur each year, and HCC is estimated to cause 600,000 mortalities globally each year (1). One characteristic of HCC is the dysregulation of cell growth. HCC has a complex, multistep and heterogeneous malignant tumourigenesis. The pathogenesis of HCC involves a host of genetic and environmental factors and the modulation of molecular signalling pathways that have been implicated in the malignant transformation of hepatocytes and tumour progression (24) .
XPD is a DNA repair gene that is also known as ERCC2 (25) . XPD plays a key role in NER, a process that is crucial in the elimination of specific DNA cross-links, ultraviolet photo-lesions and bulky chemical adducts (26, 27) . XPD is a DNA-dependent ATPase/helicase that is associated with the transcription factor IIH complex and acts to perform a pivotal function in the NER pathway. XPD is involved in the opening of the DNA duplex, which is necessary for the excision of the fragment of DNA containing the damaged base (28, 29) .
Numerous meta-analyses have been performed to investigate the association between XPD polymorphism and the risk of different types of cancer, e.g., prostate (30-32), lung (33-35), gastric (8, 36) , breast (7, 37, 38) , head and neck (39,40) and Gln polymorphism-negative hepatitis B virus infection interaction in the dominant model (Gln/Gln + Lys/Gln vs. Lys/Lys). The squares and horizontal lines correspond to the study-specific OR and 95% CI. The area of the squares reflects the study-specific weight. The diamond represents the pooled OR and 95% CI. OR, odds ratio; CI, confidence interval. Gln polymorphism and HCC risk in HBV + and HBV -patients. Furthermore, the P-value of the Q-test for heterogeneity was significant. Considering the limited number of studies and P-value of the Q-test for heterogeneity in this meta-analysis, the present results should be interpreted with caution.
A number of limitations to this meta-analysis should be considered in the interpretation of the results. First, a common limitation of meta-analyses is study heterogeneity. Heterogeneity is often caused by variations in the environmental and genetic backgrounds of the study participants, which is unavoidable when assessing several studies. Evidence of study heterogeneity was found in the present meta-analysis, presumably due to the fact that the number of included studies was small, and the frequency of the demographic variables for the cases and controls in one study was not matched in age, gender or histological type, among other factors. A second limitation was that the control groups were selected from different populations. In certain studies, the controls were healthy individuals, while in other studies the reference group was selected from hospital patients without organic gastric cancer; thus, there was a possibility of non-differential misclassification bias, since these studies may have included control groups with different risks of developing HCC. Thirdly, the present results were based on single-factor estimates without adjustment for other risk factors, including AFB1 intake, excessive consumption of alcohol and other lifestyle factors. Finally, the XPD gene could influence HCC susceptibility through interaction with other genes; however, no gene-gene interaction analyses were performed in this study.
In conclusion, the present meta-analysis provides limited evidence to support the association of XPD Lys 
